Ksana Health Joins Novo Nordisk’s Global Prevention Accelerator

Pilot Program Leverages Continuous Objective Measurement to Identify and Address Aspects of Behavior Related to Improved Health Outcomes

Ksana Health has been selected by Novo Nordisk’s Global Prevention Accelerator to apply continuous objective behavioral health measurement to improve health outcomes.

Press release: Digital Behavioral Health Innovator Ksana Health Joins Novo Nordisk’s Global Prevention Accelerator

Organizations were selected based on a set of criteria including the ability to make a global impact and provide scalable digital solutions that can be adapted for local populations.

“Novo Nordisk is embarking on new territory with great excitement in collaboration with Ksana Health. Ksana Health has a really interesting approach and we look forward to gaining learnings from the pilot. Furthermore, I am excited to see what this collaboration will bring for the future.”

Katrine DiBona, head of Global Public Affairs and Sustainability, Novo Nordisk A/S

Ksana Health will pilot its remote measurement platform, Vira, for health systems and care providers as part of the Prevention Accelerator. Vira delivers continuous objective measurement through a digitally enhanced platform that collects and converts measurable behavioral patterns into actionable, objective insights for individuals and their practitioners. In addition, Vira can help guide the development of a personalized plan supporting positive behavior change through timely, data-driven communication.